Drug Shortage Report for BRIVLERA

Last updated on 2021-01-16 History
Report ID 131503
Drug Identification Number 02452987
Brand name BRIVLERA
Common or Proper name BRIVLERA
Company Name UCB CANADA INC
Market Status MARKETED
Active Ingredient(s) BRIVARACETAM
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration ORAL
Packaging size 300mL
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2021-01-13
Actual start date 2021-01-13
Estimated end date 2021-01-22
Actual end date 2021-01-15
Shortage status Resolved
Updated date 2021-01-16
Company comments
Health Canada comments
Contact Address 2201 BRISTOL CIRCLE
OAKVILLE, ONTARIO
CANADA L6H 0J8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-01-16 English Compare
v5 2021-01-15 French Compare
v4 2021-01-15 English Compare
v3 2021-01-14 English Compare
v2 2021-01-13 French Compare
v1 2021-01-13 English Compare